Clinical Pathways Congress + Cancer Care Business Exchange

📢 Now Available: The Latest Issue of the Journal of Clinical Pathways! We're closing out 2024 with Volume 10, Issue 6, delivering cutting-edge insights to advance value-based oncology through innovation and equity. 📰 Highlights from this issue: 1. Clinical Pathways Research: Exploring challenges, adoption, and future trends. 2. Policy Analysis: The intersection of public law and private sector employer plans. 3. Multidisciplinary Care: Evolving oncology clinical pathways in chronic lymphocytic leukemia (CLL). 4. AI and Equity: Addressing bias in quality measurement. 5. Case Study: Development and analysis of a treatment timeliness dashboard for head and neck cancer patients at a tertiary academic multidisciplinary clinic. 6. Cost & Clinical Insights: Implications of using homologous recombination deficiency status to guide first-line maintenance therapy selection in advanced ovarian cancer. As we celebrate another impactful year, we thank our contributors, readers, and the community for driving meaningful conversations in oncology care. https://bit.ly/41elMXa 💬 Which article resonates with you most? Share your thoughts below! #JournalofClinicalPathways #JCP #ValueBasedCare #Oncology #ClinicalPathways #HealthcareInnovation #EquityInHealthcare

Exploring Advances in Oncology Pathways and CLL Care at Clinical Pathways Congress + Cancer Care Business Exchange (CPC+CBEx) 2024 “Shared decision-making is critical—we must elevate the patient voice to ensure long-term therapies not only extend life but improve its quality.” Dr Shaffee Bacchus, Oncology Access Lead at AbbVie, shares his insights: - The evolution of oncology pathways as a vital channel for patient access; - Breakthroughs in CLL treatment: from chemo-immunotherapies to targeted therapies like BTK and Bcl-2 inhibitors, with CAR T therapies on the horizon; and, - The essential role of multidisciplinary care teams in managing comorbidities, optimizing treatment, and enhancing quality of life. Dive into Dr Bacchus' perspectives on innovations in therapeutic options, the importance of simplified regimens, and strategies for managing adverse events. Watch the full interview here: https://lnkd.in/eukkem4p #JournalofClinicalPathways #JCP #CPCCBEX #CLL #Shareddecisionmaking #CARTtherapies #Patientaccess

At the recent Clinical Pathways Congress, a team of cancer center leaders convened with Flatiron Health team to share their best practices and most impactful strategies for developing patient navigation services. Explore our recent blog posts for key takeaways and findings here: https://lnkd.in/ecNbVeF9

Want to know about MAI? Chris Van Denburg shared insights on our Market Access Insights team at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange, the official Congress for the Journal of Clinical Pathways. In this conversation, Chris dives into what makes our MAI team unique and how we’re pushing the boundaries in market access to bring actionable insights to the forefront. Want to learn more about MAI? Sign up for updates delivered right to your inbox: Link to contact us form 📩 https://lnkd.in/gBAdZs6a #HMPMarketAccessInsights #AboutUs #MarketAccess #OncologyMarketAccess

Insights from Clinical Pathways Congress + Cancer Care Business Exchange: Presenters at the 2024 Clinical Pathways Congress + Cancer Care Business Exchange shared how their institutions integrate medical oncology and surgical specialties for genitourinary cancers and some of the challenges they face both clinically and organizationally in taking care of this patient population. Access our article to learn more about this session. #journalofclinicalpathways #CPCCBEx #genitourinarycancers #clinicalchallenges #oncology #patientcare

Pharma Day brings together manufacturers, leading pathway developers, and end-users for a deep dive into the current state of clinical pathways and considerations for building successful partnerships.   Interested in joining the conversation next year? Reach out to Sara S. to learn more about how your team can get involved.

Such a pleasure moderating a panel on Strategies for Patient Navigation Services with these incredible women Susan Sabo-Wagner MSN, RN, OCN, NEA-BC, Kathy Oubre, MS and Kathryn Paliotta. I continue to be inspired by all that they do to run world-class oncology practices and provide exceptional care to their patients, and it’s such a joy working alongside them as their tech partner. Thank you for making this years Clinical Pathways Congress + Cancer Care Business Exchange great!

The Clinical Pathways Congress + Cancer Care Business Exchange panel, “The Virtual Cancer Clinic: Extending Care to the Home and Reimagining the Patient Experience,” was an enlightening discussion that brought together some of the most forward-thinking minds in oncology. This conversation explored the future of on-demand cancer care, focusing on how we can enhance patient experiences by integrating virtual solutions and extending care beyond traditional clinical settings. We are immensely grateful to our esteemed panelists, who shared their invaluable insights and expertise: - Moderator, Dan Nardi, CEO of Reimagine Care, who is at the forefront of transforming oncology care delivery. - Barry Russo, CEO of The Center for Cancer and Blood Disorders, who continues to champion patient-centered care. - Shelley Fuld Nasso, CEO of the National Coalition for Cancer Survivorship whose advocacy work ensures that the voices of cancer patients and survivors are heard. - Dr. Pallav Mehta, Medical Director for Reimagine Care, whose clinical leadership is integral to our mission of bringing high-quality cancer care into the home. - Samyukta Mullangi, with Thyme Care, who brings a wealth of knowledge in designing value-based care models that prioritize patient outcomes. - Glen Peterson, Senior Director at the University of Colorado Anschutz Medical Campus, whose academic and clinical perspectives are vital to advancing innovative cancer care solutions. Thank you to each of you for your contributions to this important conversation. Together, we are reimagining what cancer care can look like, making it more accessible, patient-centered, and supportive of the journey that each individual faces. The future of cancer care is not just about treating the disease; it’s about supporting the whole person, wherever they are. To learn more about on-demand cancer care, visit reimaginecare.com.

🧬 I could listen to these smart humans talk MRDs all day! 100% of attendees agree: they left Boston >10% smarter and >10% more excited about the future of minimal residual disease testing. Thank you for distilling this space down and getting us all pumped about where we’re headed Kaylie J. Dan S. and Ira Klein ! Clinical Pathways Congress + Cancer Care Business Exchange ended on a high note 🔥

Great weekend at the Clinical Pathways Congress + Cancer Care Business Exchange! Among many terrific learnings, this stat presented by Harlan Levine is one I will not forget: --> What % of clinicians report they connect patients with supportive #cancer care services? 96%. --> What % of patients report they have not heard of #supportive care or are unsure? 61%. This is a massive disconnect that needs solving in #oncology!!